By Kashish Tandon (Reuters) -Indian drugmaker Anthem Biosciences' [ANTH.NS] $395 million IPO was fully subscribed on the ...

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

The President of the United States was in attendance at the FIFA Club World Cup Final on Sunday. Chelsea took on PSG in the ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...

MU Health Care said in a statement it has been in close communication with Anthem Monday but did not confirm whether the two ...

There have been several notable national anthem performances over the years, with some being iconic and some being downright ...

Anthem’ will disappear in early 2026. The move comes as consumer group Stop Killing Video Games fights to preserve similar ...

Baltimore-based artist Dan Deacon performed an electronic, autotuned national anthem that seemingly divided fans before the ...

BioWare is shutting down its ill-fated loot shooter, and all that will be left is a crater where the studio’s legacy once was ...